I AgreeWe use Google Analytics to understand how visitors use our website. The cookies we collect are in an anonymous form.
For more details check out Cookie Policy and our Privacy Policy

T: +44 (0) 114 290 1801
E: enquiries@glass-ts.com

USP - Ph.Eur Pharmacopoeial Harmonisation Increases Emphasis on Delamination

Make an enquiry

Make an enquiry

Thursday 5 November 2015

Pharmacopoeial Harmonisation increases emphasis on Delamination - Image Credit Nixx Photography - Shutterstock 126486218The latest revisions to international pharmacopoeia standards for glass pharmaceutical packaging has seen further harmonisation for testing requirements and see a continual increase in the necessity of delamination propensity studies across the pharmaceutical supply-chain, according to independent research and development, consultancy and testing facility, Glass Technology Services Ltd (GTS).

Commenting on the latest revisions to pharmacopoeia test methods for pharmaceutical glassware, including bottles, vials, ampoules, cartridges and syringes, GTS Laboratory Manager Daniel Capon, said:

“The United States (USP) and European (Ph. Eur.) Pharmacopoeias remain the most widely used in the global market and recent revisions to both monographs continue to harmonise requirements between the two - bringing welcome simplification and, in some cases, savings for customers that regularly test to both the USP and Ph. Eur. standards”

“The latest revisions, USP 38-NF33 and Ph. Eur 8.3, further emphasise recommendations for propensity and stability studies - with direct references now being included within both USP <660> and Ph. Eur 3.2.1 for the first time.”

“This is a key concern for many drug manufacturers looking to approve their products within EU and US marketplaces and we have seen a dramatic increase in global companies coming to us for advice, consultancy and study programmes. As such a specialist area it is understandable that there is so much concern and uncertainty in this area – we are one of only a few laboratories that hold the necessary specialist glass knowledge, experience and equipment”.

Key changes include:

  • Direct reference to the recommendation for delamination propensity or evaluation studies within both USP <660> and Ph. Eur 3.2.1 for the first time;
  • Stricter autoclave programmes within respective glass grains and surface tests across both monographs, with additional requirements for the time-temperature profiles that must be achieved in both heating and cooling of samples and the required use of external thermocouples for temperature logging;
  • Mechanical sieve-shakers/sieving machines now allowed within glass grains preparation in both the USP and Ph. Eur.

Daniel explains: 

“This ongoing harmonisation is another positive step forward and builds upon significant unification between USP 37-NF32 and Ph. Eur 8.0 in 2014 - which saw the USP adopt the Ph. Eur. glass grains and surface tests.”

“The key concern for many pharmaceutical and medical companies comes down to the growing need for glass surface delamination evaluation, propensity and stability studies. This has been a key area of support and development for us in recent years – with a range of services available and our direct involvement in research groups, including the International Commission on Glass’ Technical Committee TC12 for glass delamination”.

GTS provides accredited testing services for pharmaceutical and medical companies as well as glass manufacturers and processors and participates in collaborative studies on glass containers for pharmaceutical and medical use. In addition to United States (USP) and European Pharmacopoeia (EP/Ph. Eur) , GTS also tests to British, Russian and Japanese Pharmacopoeia standards and provides a comprehensive range of chemical analyses, performance testing, quality assessment and consultancy services.

For further information please visit www.glass-ts.com/pharmacopoeia, email enquiries@glass-ts.com or telephone +44 (0) 114 290 1801 for further information.


We provide expert analysis, testing and consultancy - conducted by our dedicated team of scientists who have expertise in glass manufacture, processing, material sciences, chemistr…

Defects and Contamination

Analysis of solid, gaseous, contamination, forming and other defects, including stone, cord, bubbles, blisters, foreign materials, bloom and delamination.


Pharmacopoeia testing for all Type I, II and III glass packaging (containers, bottles, vials, ampoules) and parenteral delivery vessels for use across the pharmaceutical and medica…


Investigative analysis where delamination is suspected and delamination propensity pre-screening as detailed in the latest USP <1660>.

Technical Consultancy

Our technical experts provide support throughout the glass supply chain - providing clients with market advantage, knowledge and technical input to improve their manufacture, proce…

Quality Assessment

The quality and performance of a product once in market is a reflection of the brand, and suppliers, identity - should that product not be fit-for-purpose, cause injury, or not per…

Accreditation Accreditation Accreditation Accreditation